12 results
10-K
2022 FY
COYA
Coya Therapeutics Inc
29 Mar 23
Annual report
4:08pm
knows or should know is likely to influence the beneficiary’s selection of a particular supplier of Medicare or Medicaid payable items or services
424B4
COYA
Coya Therapeutics Inc
30 Dec 22
Prospectus supplement with pricing info
4:17pm
more than one supplier, port closures and other restrictions resulting from the COVID-19 pandemic or future pandemics may disrupt our supply chain … selection of a particular supplier of Medicare or Medicaid payable items or services. Federal government price reporting laws require manufacturers
S-1/A
hdjlgknctw2 sv7
5 Dec 22
IPO registration (amended)
8:16am
S-1
2r6lh
18 Nov 22
IPO registration
5:06pm
CORRESP
eyeva2 vf1j1gc
18 Nov 22
Correspondence with SEC
12:00am
UPLOAD
cdsrq vae2gsqzaam
4 Nov 22
Letter from SEC
12:00am
DRS/A
uc27lc09eunm725kt
28 Oct 22
Draft registration statement (amended)
12:00am
DRS/A
hpk uiktxmdhiz
7 Oct 22
Draft registration statement (amended)
12:00am
DRS
fzpkxp
19 Aug 22
Draft registration statement
12:00am
- Prev
- 1
- Next